Cleared Special

K073023 - STERILS SINGLE-USE I/A HANDPIECES

K073023 is an FDA 510(k) clearance for STERILS SINGLE-USE I/A HANDPIECES, manufactured by Bausch & Lomb, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Special 510(k) pathway after a 138-day FDA review.

K073023 · Bausch & Lomb, Inc. · Ophthalmic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
138d
Days
Class 2
Risk

K073023 is an FDA 510(k) clearance for the STERILS SINGLE-USE I/A HANDPIECES. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Bausch & Lomb, Inc. (Rochester, US). The FDA issued a Cleared decision on March 12, 2008 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K073023

510(k) Number K073023 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 26, 2007
Decision Date March 12, 2008
Days to Decision 138 days
Submission Type Special
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 110d · This submission: 138d
Pathway characteristics
Modification to existing cleared device.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 271
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K073023.
VISUAL PHACOEMULSIFICATION SYSTEM, MODEL 551
K080803 · American Optisurgical, Inc. · Sep 2008
BAUSCH & LOMB D4600A AIR EXCHANGE LINE PACK
K082132 · Bausch & Lomb, Inc. · Aug 2008
ALCON VISION SYSTEM
K063583 · Alcon · May 2008
BAUSCH & LOMB NGX MICROSURGICAL SYSTEM
K063331 · Bausch & Lomb, Inc. · Dec 2006
THE AMO OPHTHALMIC SURGICAL SYSTEM
K060366 · Advanced Medical Optics, Inc. · Apr 2006
MICROPULSE PHACOEMULSIFICATION SYSTEM
K051186 · Trillium Medical, Inc. · Aug 2005
K073023 · STERILS SINGLE-USE I/A HANDPIECES
Download PDF FDA Summary Bausch & Lomb, Inc.